Nova Patents
PL3206716T3

Use of cannabinoids in the treatment of atonic seizures in lennox-gastaut syndrome

Abstract

This record has no abstract on file.

Term

9.1 yearsto projected expiry

Projected expiry 14 October 2035, counted from filing; an application has no term until it is granted.

  1. Priority and filed
  2. Published
  3. Today
  4. Projected expiry

77 members in 22 offices

This recordMember, by publication date12 more offices are in the list below

Members77

Family members, oldest first
DocumentOfficeKind
GB201418171D0United KingdomD0
GB2531282AUnited KingdomA
CA2963208A1CanadaA1
CA3232241A1CanadaA1
WO2016059403A1World Intellectual Property Organization (WIPO)A1
US2016166515A1United States of AmericaA1
AU2015332212A1AustraliaA1
IL251529A0IsraelA0
IL251529D0IsraelD0
US2017172941A1United States of AmericaA1
MX2017004762AMexicoA
EP3206716A1European Patent Office (EPO)A1
US2017266126A1United States of AmericaA1
JP2017531667AJapanA
BR112017007777A2BrazilA2
US10092525B2United States of AmericaB2
US10111840B2United States of AmericaB2
US10137095B2United States of AmericaB2
US2019091171A1United States of AmericaA1
US2020000741A1United States of AmericaA1
JP6656241B2JapanB2
US2020069608A1United States of AmericaA1
JP2020073580AJapanA
US10709673B2United States of AmericaB2
US10709674B2United States of AmericaB2
EP3206716B1European Patent Office (EPO)B1
DK3206716T3DenmarkT3
PT3206716TPortugalT
MX2020006951AMexicoA
US2020323792A1United States of AmericaA1
LT3206716TLithuaniaT
RS60767B1SerbiaB1
SI3206716T1SloveniaT1
SMT202000474T1San MarinoT1
EP3735964A1European Patent Office (EPO)A1
US10849860B2United States of AmericaB2
PL3206716T3This recordPolandT3
HRP20201230T1CroatiaT1
ES2811327T3SpainT3
ES2811327T8SpainT8
US10966939B2United States of AmericaB2
AU2015332212B2AustraliaB2
IL251529AIsraelA
IL251529BIsraelB
IL281793AIsraelA
IL281793D0IsraelD0
HUE053262T2HungaryT2
US2021196651A1United States of AmericaA1
AU2021204353A1AustraliaA1
US2021244685A1United States of AmericaA1
US11096905B2United States of AmericaB2
US11154517B2United States of AmericaB2
CY1123229T1CyprusT1
US2022000800A1United States of AmericaA1
JP2022066354AJapanA
US11446258B2United States of AmericaB2
IL281793BIsraelB
IL296865AIsraelA
US2022395471A1United States of AmericaA1
IL281793B2IsraelB2
MX2023003337AMexicoA
US11633369B2United States of AmericaB2
AU2021204353B2AustraliaB2
US2023248664A1United States of AmericaA1
AU2023258400A1AustraliaA1
JP2024012681AJapanA
NZ730982ANew ZealandA
NZ768001ANew ZealandA
IL296865B1IsraelB1
IL296865B2IsraelB2
MX374009BMexicoB
US12318356B2United States of AmericaB2
US2025248950A1United States of AmericaA1
CA2963208CCanadaC
AU2023258400B2AustraliaB2
US12427160B2United States of AmericaB2
AU2025271332A1AustraliaA1